Autopsy report · NCT03102190

Trial of Topical Verapamil in Chronic Rhinosinusitis With Nasal Polyps

“Phase II funding not available”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Ran for about 10 months before it stopped.
• 6 participants enrolled.
• Results were posted on the registry 1 year 3 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Benjamin Bleier

Sponsor type

University, hospital or other

Conditions

Sinusitis; Nasal Polyps

Interventions

Verapamil Hydrochloride Intranasal

Participants

6

Sites

1

Countries

United States

Trials that died the same way

• Protandim and the Metabolic Syndrome
  “funding not available” (79% match in meaning)
• Characterization of Innate Immune System in Patients With Luminal Advanced Breast Cancer
  “Lack of funding to continue the research into Phase II” (77% match in meaning)
• Trial of MK-2206 + Endocrine Treatment in Patients With Hormone Receptor Positive Breast Cancer
  “Funding was not available” (76% match in meaning)
• Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junction
  “Lost funding for Phase II portion of study” (75% match in meaning)
• Evaluation and Adverse Event Surveillance for Initial Implementation of ShangRing Circumcision in Mozambique
  “Funding no longer available” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.